Species | SCI model | Treatments | Main funding | References | ||
---|---|---|---|---|---|---|
Location | Treat | Time and duration | ||||
Male C57BL/6 mice | T9–11 contusion | Injection via tail vein | NGF or NGF-NVs solution (10 mg/kg/day) | Immediately after SCI, once per day until the animals were executed | Iimproved the survival of neurons and good behavioral and histological recovery effects after SCI | [28] |
Female Wistar rats | T8–T9 contusion | At lesion | 5 μl of hydrogel and 1 × 105 of transduced hADSCs in 5 μl hydrogel were injected | One-week post-injury | Repair damaged spinal cord and improve locomotor function | [33] |
BALB/c mice | – | At lesion Intravenously | n(NGF) 2.5 mg kg−1 of body weight | Every 4 days for 3 weeks | Extend the blood circulation half-life and functional recovery | [34] |
Female Sprague-Dawley (SD) rats | T9 transection | At lesion | PDA-PLGA/NGF scaffolds | After SCI, once | Promote the proliferation and neuronal differentiation of NSCs in vitro | [35] |
Female SD rats | T9–T10 contusion | Orthotopic injection at lesion | Orthotopic injection of HP, free GFs or GFs-HP solution (20 µL) | After SCI, single injection | Improve neuronal survival, axon regeneration, reactive astrogliosis suppression and locomotor recovery | [36] |
Female Sprague-Dawley rats | T8 contusion | Injection into the tail vein | bFGF-loaded dual-targeting liposomes (bFGF@Lip-Cp&Rp) | 0.5 mL liposomes (equivalent to 10 μg/mL of bFGF) weekly for 28 days | Repair the BSCB, enhance expression of tight-junction protein, advance M1 to M2 macrophage transformation, increase angiogenesis Led to smaller spinal cord lesion cavity, neuronal and axonal regeneration, recovery of limb motor function | [37] |
Female Sprague-Dawley rats | T9 to 10 transection | At lesion | 4 mm CBD-NGF/PCL/GE scaffold | After SCI | Improvement in motor and neurological functions in the hind limbs of SCI rats and progress in the recovery of axonal transport | [38] |
Female C57BL/6 J mice | T11 contusion | At lesion | BDNF mRNA (500 ng/µl) | After SCI, single dose | Enhancement of motor function recovery | [46] |
Female Sprague-Dawley rats | T10 | At lesion | Combination of ASCs overexpressing BDNF-NT3 | After SCI | Increased formation of nerve fibers, increased GAP-43 expression, and decreased GFAP and caspase-3 expression | [47] |
Female rats | L1 contusion | – | Intraperitoneal injection of 20 mg/kg LiCl | Three days after surgery | Increased BDNF/TrkB expression and decreased of apoptosis cell death | [55] |
Acutely injured spinal cord slice cultures | – | – | Neural crest stem cells | – | Inhibition of glial activation by secretion of BDNF | [56] |
Male Sprague-Dawley rats | T9 | At the SCI site | Human urine stem cells combined with chondroitinase ABC | 3 days after the completion of SCI model | Promoted BDNF and NGF, Improved motor function | [58] |
Male Wistar rats | T10 | At lesion | Epidural electrical stimulation | 1 h each day for 14 consecutive days | Increased the expression of Wnt3, Wnt7, β‐catenin, cyclin D1, Nestin, and BDNF | [68] |
Male Sprague-Dawley rats | T9–T10 contusion | At lesion | Treadmill exercise with bone marrow stromal cells | Bone marrow stromal cells: 1 week after SCI, Treadmill exercise: 6 days per a week for 6 weeks | Activated ERK1/2 pathway, and decreased Apoptosis | [62] |
Female Sprague-Dawley rats | T10 contusion | At lesion | HAMC-KAFAK/BDNF hydrogel | After 5 min of SCI | Promoted nerve regeneration, and reduced proinflammatory cytokines expression and cystic cavitation, as well as decreased glial scar formation | [64] |
Male Sprague-Dawley rats | T11 contusion | – | Intrathecal delivery of BDNF-overexpressing human neural stem cells | One week after the injury | Reduced numbers of Iba1- and iNOS-positive inflammatory cells as well as GFAP-positive astrocytes, Recovery functional, increased volume of spared myelination | [65] |
Female Wistar rats | T9 contusion | At lesion | A silk fibroin/alginates/glial cell line-derived neurotrophic factor (SF/AGs/GDNF) scaffold seeded with human umbilical cord mesenchymal stem cells (hUCMSCs) | After SCI | Increased the number of surviving neurons | [74] |
Male Wistar rats | T10 contusion | At lesion | GDNF gene-engineered adipose-derived stem cells seeded Emu oil-loaded electrospun nanofibers | After SCI | Recovery of motor function, reduced the size of the lesion cavity and axonal demyelination | [76] |
Female Sprague-Dawley rats | T9–T10 contusion | - | NT-3 | After SCI | Inhibited excessive autophagy of oligodendrocytes, and promoted the recovery of motor function | [83] |
Rat | T8 transection | – | NT-3 | After SCI | Inhibited the MAPK signaling pathway, decreased inflammation | [85] |
Female Sprague-Dawley rats | T9 | At lesion | Neurotrophin-3-loaded multichannel nanofibrous scaffolds | After SCI | Promoted anti-inflammation, neuronal differentiation, and functional recovery | [86] |